DIAGNOS INC (DGNOF:OTCMKTS)
$0.287 0.0154 (5.6701%)
Analysed DIAGNOS INC (DGNOF:OTCMKTS) News Sources
DIAGNOS to Present at the Emerging Growth Conference on June 10, 2026
03-06-2026
yahoo.com
Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform
05-06-2026
yahoo.com
Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
09-06-2026
yahoo.com
DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting
12-06-2026
yahoo.com
DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform
16-06-2026
yahoo.com
DIAGNOS Announces Shares for Debt Settlement
18-06-2026
yahoo.com
DIAGNOS to Extend the Exercise Period of Stock Warrants
07-07-2026
yahoo.com
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream
14-07-2026
yahoo.com
DIAGNOS Receives Health Canada Medical Device Licence for CARA System, Bringing AI-Assisted Retinal Image Analysis to Canadian Optometrists
27-07-2026
yahoo.com
DIAGNOS Receives Saudi FDA Medical Device License for CARA System, Bringing AI-Assisted Retinal Image Analysis to Saudi Arabia
13-08-2026
yahoo.com
What is the current price of DIAGNOS INC (DGNOF:OTCMKTS)?
The current price of DIAGNOS INC (DGNOF:OTCMKTS) is $0.287.
DIAGNOS INC (DGNOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of DIAGNOS INC (DGNOF:OTCMKTS) since the previous trading day is $0.0154.
DIAGNOS INC (DGNOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of DIAGNOS INC (DGNOF:OTCMKTS) since the previous trading day is 5.6701%.
What is the most recent average sentiment score for DIAGNOS INC (DGNOF:OTCMKTS)?
The most recent average sentiment score for DIAGNOS INC (DGNOF:OTCMKTS) is 56 out of 100.
What is the most recent average sentiment for DIAGNOS INC (DGNOF:OTCMKTS)?
The most recent sentiment for DIAGNOS INC (DGNOF:OTCMKTS) is .
SEC-8K** Filing Available For DIAGNOS INC (DGNOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.